ProLymph Nano ProLymph Nano is an enabling drug delivery technology that focuses on the lymphatic system and the unique challenges and opportunities it presents.

The lymphatic system transports fluids, lipids, and immune cells in the body. It is involved in our healthy physiology as well as many diseases. However, due to the how the lymphatic system is structured, it is difficult to dose and target with therapies. As a result, managing lymphatic pathologies remains challenging.

Because diseases of the lymphatic system afflict a staggering number of people both in the U.S. as well as globally, Treme Bio’s technology offers unique opportunities for market differentiation and impact.

  • About Treme Bio
  • Patented ProLymphNano – A New Paradigm for Drug Delivery Scalable Commercial Attributes
  • Patented
  • Biodegradable and biocompatible
  • Payloads of diverse molecules (actives)
  • Easily formulated
  • Releases actives into the lymphatic system for days to weeks
  • Economical to manufacture

Our Team

  • Susan Thomas, PhD
  • Co-Founder
  • Thomas Kim, J.D.
  • CEO & Co-Founder
  • Former Biotech
    General Counsel
    Serial Entrepreneur
  • Jessica Lee, MPH
  • Strategy & Clinical
  • Dev Ops
  • David Francis, PhD
  • CSO
  • Lymphatic Drug Delivery
  • Sean Johnston, PHD
  • CMC

We look forward to hearing from you!

* indicates required
  • © 2025 Treme Bio All rights reserved.